S-Bank Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$952K Buy
+39,521
New +$1.03M 0.13% 98
2025
Q4
Sell
-36,624
Closed -$933K 200
2025
Q3
$933K Sell
36,624
-477
-1% -$11.8K 0.12% 103
2025
Q2
$899K Sell
37,101
-2,044
-5% -$47.7K 0.13% 108
2025
Q1
$992K Buy
+39,145
New +$1.02M 0.19% 89

Other funds holding PFE

S-Bank Fund Management's PFE Position: Q2 2026 in Review

S-Bank Fund Management opened a new position in Pfizer (PFE) in Q2 2026: 39,521 shares worth $952K. The stake represents 0.13% of the portfolio and ranks #98 among its holdings. This is a return to the name: S-Bank Fund Management previously reported a position in PFE as recently as Q3 2025.

S-Bank Fund Management first reported a position in PFE in Q1 2025 and has held it in 4 quarters since. The position peaked at $992K in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • S-Bank Fund Management held 39,521 shares of Pfizer worth $952K as of Q2 2026.
  • Pfizer was a new S-Bank Fund Management position in Q2 2026.
  • Pfizer made up 0.13% of S-Bank Fund Management's portfolio in Q2 2026, its #98 holding.
  • S-Bank Fund Management first reported a position in Pfizer in Q1 2025 and has held it in 4 quarters since.
  • S-Bank Fund Management's Pfizer position peaked at $992K in Q1 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.